SCHEMBL16259200

SCHEMBL16259200

CC(O)(c1cccnc1)c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
KCNA5 P22460 4/20 0.45
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
LMNA P02545 1/20 0.44
CYP11B1 P15538 1/20 0.44
CYP11B2 P19099 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
CYP19A1 P11511 4/20 0.44
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HIF1A Q16665 1/20 0.41
HDAC6 Q9UBN7 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16231359 0.85 SMN1; SMN2 (0.50) SMN1; SMN2L3MBTL1CYP3A4CYP19A1HDAC6
SCHEMBL31143640 0.84 SMN1; SMN2 (0.57) SMN1; SMN2L3MBTL1CYP3A4TDP1CYP2C19
SCHEMBL23619158 0.84 SMN1; SMN2 (0.57) SMN1; SMN2L3MBTL1CYP3A4TDP1CYP2C19
SCHEMBL7559746 0.84 SMN1; SMN2 (0.57) SMN1; SMN2L3MBTL1CYP3A4TDP1CYP2C19
SCHEMBL16230666 0.84 SMN1; SMN2 (0.46) SMN1; SMN2L3MBTL1KCNA5CYP1A2CYP3A4
SCHEMBL1375896 0.82 CYP19A1 (0.55) KCNA5CYP1A2CYP3A4LMNACYP11B1
SCHEMBL18595142 0.81 CYP19A1 (0.45) SMN1; SMN2L3MBTL1KCNA5CYP1A2CYP3A4
SCHEMBL30927960 0.80 KCNA5 (0.56) KCNA5CYP1A2CYP3A4LMNACYP11B1
SCHEMBL29226694 0.80 KCNA5 (0.56) KCNA5CYP1A2CYP3A4LMNACYP11B1
SCHEMBL19013951 0.80 KCNA5 (0.56) KCNA5CYP1A2CYP3A4LMNACYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017106568-A1 COMBINATION OF A JAK INHIBITOR AND A BROMODOMAIN INHIBITOR FOR TREATING CANCER GILEAD SCIENCES, INC. (US) 2017-06-22 WO disclosed
WO-2014182929-A1 BENZIMIDAZOLE DERIVATIVES AS BROMODOMAIN INHIBITORS GILEAD SCIENCES, INC. (US) 2014-11-13 WO disclosed